Literature DB >> 20620497

Renal acute cellular rejection: correlation between the immunophenotype and cytokine expression of the inflammatory cells in acute glomerulitis, arterial intimitis, and tubulointerstitial nephritis.

A Sementilli1, M Franco.   

Abstract

BACKGROUND: Acute renal transplant glomerulopathy (ARTG) refers to a glomerular inflammation mainly within the three 1st months posttransplantation, characterized by the influx of lymphomononuclear cells and swelling of endothelial and mesangial cells. The reported occurrence of ARTG is between 4.3% and 14% of all renal allografts. Investigations on the pathogenesis and on the impact on graft survival have been critically reviewed. The simultaneous occurrence of ARTG and acute vascular rejection (AVR) is common. However, cases of ARTG with no vascular inflammation suggest distinct pathogenic mechanisms for the entities. The objective of the present work was to compare the immunophenotype of the infiltrating cells and the cytokine immunoexpression (ICE) in ARTG with those of arterial intimal inflammation in AVR. We also compared the glomerular ICE with that in acute tubulointerstitial rejection and in arterial intimal inflammation.
METHODS: Forty kidney transplant biopsy specimens were allocated to 4 groups: 10 cases of acute tubular necrosis without ARTG or AVR (group I, Control); 10 cases of ARTG without AVR (group II); 10 cases of ARTG with AVR (group III); and 10 cases of AVR without ARTG (group IV).
RESULTS: The immunoexpressions of CD68 (macrophages), CD8 (cytotoxic T lymphocyte), CD4 (helper T lymphocyte), CD20 (B lymphocyte), S100 protein (antigen-presenting cells), interleukin (IL)-4, IL-10, and interferon (INF)-gamma-positive cells were evaluated in the glomeruli, arterial intima, and tubulointerstitium. In the comparative study between ARTG and arterial intimal inflammation, CD68+ cells predominated in the ARTG and T CD8+ cells in inflammation; the cytokine patterns were similar in both cases (IL-4 predominance).
CONCLUSIONS: Altogether, the data suggested similar pathogenic mechanisms, with mild sequential differences, for the glomerulitis, intimitis, and tubulointerstitial inflammation in cellular acute rejection. These findings seem to confirm the immunological nature of ARTG, indicating that ARTG might be included in the Banff classification as an additional parameter for acute rejection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620497     DOI: 10.1016/j.transproceed.2009.11.042

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  12 in total

1.  Inducible pluripotent stem cell-derived mesenchymal stem cell therapy effectively protected kidney from acute ischemia-reperfusion injury.

Authors:  Sheung-Fat Ko; Yen-Ta Chen; Christopher Glenn Wallace; Kuan-Hung Chen; Pei-Hsun Sung; Ben-Chung Cheng; Tien-Hung Huang; Yi-Ling Chen; Yi-Chen Li; Hsueh-Wen Chang; Mel S Lee; Chih-Chao Yang; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

2.  Inhibition of histone methyltransferase G9a effectively protected the kidney against ischemia-reperfusion injury.

Authors:  Peihsun Sung; Chihchao Yang; John Y Chiang; Chihhung Chen; Chiwen Luo; Honkan Yip
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

3.  Extendin-4 protects kidney from acute ischemia-reperfusion injury through upregulation of NRF2 signaling.

Authors:  Yen-Yi Zhen; Chih-Chao Yang; Chi-Chih Hung; Chia-Chang Lee; Chen-Chang Lee; Chien-Hsing Wu; Yen-Ta Chen; Wei-Yu Chen; Kuan-Hung Chen; Hon-Kan Yip; Sheung-Fat Ko
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

4.  Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model.

Authors:  Cheuk-Kwan Sun; Chia-Hung Yen; Yu-Chun Lin; Tzu-Hsien Tsai; Li-Teh Chang; Ying-Hsien Kao; Sarah Chua; Morgan Fu; Sheung-Fat Ko; Steve Leu; Hon-Kan Yip
Journal:  J Transl Med       Date:  2011-07-22       Impact factor: 5.531

5.  Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.

Authors:  Yen-Ta Chen; Cheuk-Kwan Sun; Yu-Chun Lin; Li-Teh Chang; Yung-Lung Chen; Tzu-Hsien Tsai; Sheng-Ying Chung; Sarah Chua; Ying-Hsien Kao; Chia-Hong Yen; Pei-Lin Shao; Kuan-Cheng Chang; Steve Leu; Hon-Kan Yip
Journal:  J Transl Med       Date:  2011-05-05       Impact factor: 5.531

6.  Brazilin exerts protective effects against renal ischemia-reperfusion injury by inhibiting the NF-κB signaling pathway.

Authors:  Yanyan Jia; Jinyi Zhao; Meiyou Liu; Bingling Li; Ying Song; Yuwen Li; Aidong Wen; Lei Shi
Journal:  Int J Mol Med       Date:  2016-05-31       Impact factor: 4.101

7.  Effects of apigenin on the expression levels of B-cell lymphoma-2, Fas and Fas ligand in renal ischemia-reperfusion injury in rats.

Authors:  Yang Liu; Xiuheng Liu; Lei Wang; Yang Du; Zhiyuan Chen; Hui Chen; Jia Guo; Xiaodong Weng; Xiao Wang; Ming Wang; Zhishun Wang
Journal:  Exp Ther Med       Date:  2017-10-02       Impact factor: 2.447

8.  Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury.

Authors:  Yen-Ta Chen; Chih-Chau Yang; Yen-Yi Zhen; Christopher Glenn Wallace; Jenq-Lin Yang; Cheuk-Kwan Sun; Tzu-Hsien Tsai; Jiunn-Jye Sheu; Sarah Chua; Chia-Lo Chang; Chung-Lung Cho; Steve Leu; Hon-Kan Yip
Journal:  Stem Cell Res Ther       Date:  2013-05-31       Impact factor: 6.832

9.  Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.

Authors:  Yen-Ta Chen; Tzu-Hsien Tsai; Chih-Chau Yang; Cheuk-Kwan Sun; Li-Teh Chang; Hung-Hwa Chen; Chia-Lo Chang; Pei-Hsun Sung; Yen-Yi Zhen; Steve Leu; Hsueh-Wen Chang; Yung-Lung Chen; Hon-Kan Yip
Journal:  J Transl Med       Date:  2013-10-25       Impact factor: 5.531

10.  DPP-4 enzyme deficiency protects kidney from acute ischemia-reperfusion injury: role for remote intermittent bowel ischemia-reperfusion preconditioning.

Authors:  Yen-Ta Chen; Christopher Glenn Wallace; Chih-Chao Yang; Chih-Hung Chen; Kuan-Hung Chen; Pei-Hsun Sung; Yung-Lung Chen; Han-Tan Chai; Sheng-Ying Chung; Sarah Chua; Fan-Yen Lee; Sheung-Fat Ko; Mel S Lee; Hon-Kan Yip
Journal:  Oncotarget       Date:  2017-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.